Kiniksa Pharmaceuticals Ltd (KNSA)
17.88
+0.27
(+1.53%)
USD |
NASDAQ |
Apr 26, 16:00
17.88
0.00 (0.00%)
After-Hours: 20:00
Kiniksa Pharmaceuticals Market Cap: 1.268B for April 26, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 25, 2024 | 1.249B |
| April 24, 2024 | 1.267B |
| April 23, 2024 | 1.254B |
| April 22, 2024 | 1.213B |
| April 19, 2024 | 1.200B |
| April 18, 2024 | 1.197B |
| April 17, 2024 | 1.202B |
| April 16, 2024 | 1.239B |
| April 15, 2024 | 1.237B |
| April 12, 2024 | 1.221B |
| April 11, 2024 | 1.250B |
| April 10, 2024 | 1.232B |
| April 09, 2024 | 1.252B |
| April 08, 2024 | 1.248B |
| April 05, 2024 | 1.264B |
| April 04, 2024 | 1.275B |
| April 03, 2024 | 1.288B |
| April 02, 2024 | 1.323B |
| April 01, 2024 | 1.391B |
| March 28, 2024 | 1.393B |
| March 27, 2024 | 1.412B |
| March 26, 2024 | 1.410B |
| March 25, 2024 | 1.409B |
| March 22, 2024 | 1.410B |
| March 21, 2024 | 1.398B |
| Date | Value |
|---|---|
| March 20, 2024 | 1.397B |
| March 19, 2024 | 1.391B |
| March 18, 2024 | 1.383B |
| March 15, 2024 | 1.412B |
| March 14, 2024 | 1.437B |
| March 13, 2024 | 1.445B |
| March 12, 2024 | 1.443B |
| March 11, 2024 | 1.436B |
| March 08, 2024 | 1.469B |
| March 07, 2024 | 1.501B |
| March 06, 2024 | 1.483B |
| March 05, 2024 | 1.425B |
| March 04, 2024 | 1.426B |
| March 01, 2024 | 1.535B |
| February 29, 2024 | 1.493B |
| February 28, 2024 | 1.438B |
| February 27, 2024 | 1.475B |
| February 26, 2024 | 1.424B |
| February 23, 2024 | 1.412B |
| February 22, 2024 | 1.389B |
| February 21, 2024 | 1.406B |
| February 20, 2024 | 1.404B |
| February 16, 2024 | 1.405B |
| February 15, 2024 | 1.421B |
| February 14, 2024 | 1.401B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
287.53M
Minimum
Oct 18 2019
1.636B
Maximum
Feb 19 2021
970.63M
Average
966.01M
Median
Feb 09 2023
Market Cap Benchmarks
| Amicus Therapeutics Inc | 3.035B |
| Geron Corp | 2.070B |
| United Therapeutics Corp | 11.00B |
| Vanda Pharmaceuticals Inc | 265.25M |
| TG Therapeutics Inc | 2.079B |
Market Cap Related Metrics
| PE Ratio | 162.55 |
| PS Ratio | 4.300 |
| Price | 17.88 |
| Earnings Yield | 0.62% |
| Normalized PE Ratio | 162.55 |